M-TEER was feasible and safe in selected patients with advanced heart failure, although their anatomical and clinical features contributed to greater procedural complexity.
M-TEER is feasible and safe in selected patients with advanced heart failure, despite anatomical and clinical features that increase procedural complexity.
Absolute Event Rate: 0% vs 0%
M-TEER was feasible and safe in selected patients with advanced HF. This cohort presented anatomical and clinical features that may have contributed to greater procedural complexity.
Crivelaro et al. (Mon,) reported a other. M-TEER was feasible and safe in selected patients with advanced heart failure, although their anatomical and clinical features contributed to greater procedural complexity.